Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Neurogastroenterol Motil. 2018 Feb 28;30(7):e13313. doi: 10.1111/nmo.13313

Table 1.

Demographics of participants in the studies, with participants in the two trials assigned to placebo grouped together

Mean ± SEM Drug Placebo (n=31)
Liraglutide (n=18) Exenatide (n=10)
Gender (% Female) 89 % 60 % 80.6 %
Age (years) 41.4 ± 2.6 39.0 ± 3.6 38.4 ± 2.2
Baseline BMI (Kg/m2) 37.4 ± 1.0 34.6 ± 0.9 35.7 ±0.7